Skip to main content
Erschienen in: Clinical Oral Investigations 4/2021

Open Access 07.09.2020 | Original Article

Does implantoplasty affect the failure strength of narrow and regular diameter implants? A laboratory study

verfasst von: Kristina Bertl, Flemming Isidor, Per Vult von Steyern, Andreas Stavropoulos

Erschienen in: Clinical Oral Investigations | Ausgabe 4/2021

Abstract

Objective

To assess whether the impact of implantoplasty (IP) on the maximum implant failure strength depends on implant type/design, diameter, or material.

Methods

Fourteen implants each of different type/design [bone (BL) and tissue level (TL)], diameter [narrow (3.3 mm) and regular (4.1 mm)], and material [titanium grade IV (Ti) and titanium-zirconium alloy (TiZr)] of one company were used. Half of the implants were subjected to IP in a computerized torn. All implants were subjected to dynamic loading prior to loading until failure to simulate regular mastication. Multiple linear regression analyses were performed with maximum implant failure strength as dependent variable and IP, implant type/design, diameter, and material as predictors.

Results

Implants subjected to IP and TL implants showed statistically significant reduced implant failure strength irrespective of the diameter compared with implants without IP and BL implants, respectively. Implant material had a significant impact for TL implants and for regular diameter implants, with TiZr being stronger than Ti. During dynamic loading, 1 narrow Ti TL implant without IP, 4 narrow Ti TL implants subjected to IP, and 1 narrow TiZr TL implant subjected to IP were fractured.

Conclusion

IP significantly reduced the maximum implant failure strength, irrespective implant type/design, diameter, or material, but the maximum implant failure strength of regular diameter implants and of narrow BL implants remained high.

Clinical Relevance

IP seems to have no clinically relevant impact on the majority of cases, except from those of single narrow Ti TL implants, which may have an increased risk for mechanical complications. This should be considered for peri-implantitis treatment planning (e.g., communication of potential complications to the patient), but also in the planning of implant installation (e.g., choosing TiZr instead of Ti for narrow implants).
Hinweise

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Overt peri-implantitis lesions regularly require a surgical intervention to achieve disease resolution [1, 2]. Depending on defect morphology and treatment approach, implantoplasty (IP), i.e., the mechanical removal of the implant threads and smoothening of the implant surface [3, 4], can be part of the surgical treatment protocol for implants with a rough surface. IP aims to achieve implant surface decontamination and also to reduce the risk of reinfection, and is recommended at those aspects of the implant, where bone healing and/or re-osseointegration is not expected. Although the clinical significance of IP (e.g., reduced bleeding indices and/or probing pocket depths, improved bone levels, etc.) has been confirmed only in a single randomized controlled clinical trial [3, 4], positive results have been reported in several case series (e.g., [512]), and IP appears as a widely used procedure.
Nevertheless, IP unavoidably causes a reduction of the implant mass, and thus it may weaken implant strength and increase implant fracture rate. A recent systematic review [13] summarized the available information on mechanical and/or biological complications due to IP. In 2 out of 3 laboratory studies identified [1416], IP reduced implant strength; i.e., standard/regular diameter implants suffered up to 40% strength reduction [14, 16]. However, several other factors (e.g., implant type/design, implant material, etc.) may additionally affect implant strength after IP, but were not addressed in those studies.
Therefore, the present laboratory study aimed to assess whether the impact of IP on implant strength depends on implant type/design, diameter, and/or material.

Material and methods

Study design and implant material

All implants included herein were from one company (Institut Straumann AG, Basel, CH), had an internal connection type, and were 10 mm in length. Fourteen implants each of different type/design [bone level (BL) and tissue level (TL; Straumann Standard Plus)], diameter [narrow (3.3 mm) and regular (4.1 mm)], and material [titanium (Ti) and titanium zirconium (TiZr) alloy] were tested. Half of the implants were subjected to IP; i.e., the sample size of each final group was 7 implants based on a previous review, which recommends at least 6 specimens with identical test parameters for fracture strength analysis after fatigue testing [17]. Herein, 7 implants per group were included to compensate for any unforeseen issues during testing (Appendix 1)(Fig. 1).

Implantoplasty

IP was performed with a computer-controlled torn (Tornos-Schaublin, 180-CCN - BL 3267, SCHAUBLIN MACHINES SA, Bévilard, CH) to ensure complete removal of the threads and the structured implant surface in a standardized fashion. Specifically, IP extended 3 mm apically from the implant neck in BL implants and from the machined/rough boundary in TL implants (Fig. 1). Depending on the implant type/design and diameter, the core diameter was reduced up to a maximum of 0.13 to 0.16 mm (i.e., narrow BL: 0.13 mm; narrow TL: 0.15 mm; regular BL: 0.14 mm; regular TL: 0.16 mm).

Mechanical testing sequence

The mechanical testing of the implant material was performed according to DIN ISO 14801 (dentistry-fatigue test for endosseous implants, International Organization for Standardization). Specifically, the implants were inserted for 7 mm in poly-methyl-methacrylate block, resulting in 3-mm exposed rough implant surface (i.e., not including the 1.8-mm polished part of the TL implants) (Fig. 2a). This approach was chosen to simulate a horizontal marginal bone loss of 3 mm in both implant types even though it was resulting in a bigger lever for the TL implants (i.e., 3 mm of the rough implant surface plus 1.8 mm of the polished neck) compared with that of the BL implants. Implants were secured with a slow-curing transparent epoxy (EpoFix; Struers, Willich, Germany) resembling a bone-like environment with ≥ 3 GPa modulus of elasticity. All implants were furnished with hemispherical shaped, purpose-made abutments (Elos Medtech, Gørløse, Denmark) with the loading center located 11 mm from the “marginal bone level”" of the implant (Fig. 2b). The abutments were connected to the implant specimens with standardized force (35 Ncm) with a ratchet. Finally, the implants were installed 30° off axis (10° by the metal holder plus 20° by the poly-methyl-methacrylate block; Fig. 2c) for both the dynamic loading and loading until implant failure.
Prior to loading until failure, the implants were subjected to dynamic loading in a preload device (MTI Engineering AB, Lund, Sweden/Pamaco AB, Malmö, Sweden) to simulate mastication. Implants were loaded for 2,000,000 cycles at 2 Hz with 23 to 226 N at room temperature in a moist environment (i.e., covered by water; Fig. 2d). Dynamic loading force applied corresponded to 10 and 50% of the mean maximum failure strength of 3 narrow diameter Ti TL implants not subjected to IP.
Thereafter, implants were subjected to loading until failure in a universal testing machine (Instron 4465; Instron Co. Ltd, Norwood, MA, USA) with crosshead speed set at 1 mm/min. Maximum implant failure strength (N) was measured herein at timepoint of (1) implant fracture or (2) severe deformation of the implant (i.e., bending of the implant and/or prosthetic component > 30°), whichever appeared first (Fig. 3).

Statistical analysis

Maximum implant failure strength (N) was defined as the primary outcome parameter. In a first step, a multiple linear regression analysis was performed for all implants with maximum implant failure strength as dependent variable and IP, implant type/design, diameter, and material as predictors. In a second step, multiple linear regression analyses were performed (1) separately for BL and for TL implants with maximum implant failure strength as dependent variable and IP, implant diameter, and material as predictors, and (2) separately for narrow and for regular diameter implants with maximum implant failure strength as dependent variable and IP, implant type/design, and material as predictors. Statistical analysis was performed using SPSS version 24.0 (SPSS Inc., Chicago, IL, USA) and p values < 0.05 were considered as statistically significant.

Results

Dynamic loading

None of the regular diameter implants and none of the narrow diameter BL implants were fractured during dynamic loading. However, 6 narrow diameter TL implants were fractured during dynamic loading. Specifically, the highest failure rate was present among the narrow diameter Ti TL implants subjected to IP, where 4 out of 7 implants were fractured; the remaining fractured implants were one narrow diameter Ti TL implant without IP and one narrow diameter TiZr TL implant subjected to IP.

Loading until implant failure

Individual results of loading until failure are presented in Fig. 4 and Table 1. One narrow diameter Ti BL implant subjected to IP had to be excluded, due to a defect in the loading until failure test; i.e., only 6 implants were included in this specific group.
Table 1
Relative reduction (in %) of the maximum implant failure strength due to IP based on the median of each group
Groups
No implantoplasty
Implantoplasty
Relative reduction
Median (1.Q; 3.Q)
Median (1.Q; 3.Q)
%
Narrow diameter
BL
Ti
564.03 (529.13; 621.22)
540.41 (518.13; 541.75)
4.2
TiZr
565.91 (530.33; 577.32)
477.32 (459.34; 506.72)
15.7
TL
Ti
472.76 (462.02; 481.08)
363.90 (362.56; 366.85)
23.0
TiZr
476.78 (473.90; 481.08)
398.26 (397.45; 408.86)
16.5
Regular diameter
BL
Ti
938.53 (921.07; 982.90)
870.34 (857.72; 876.38)
7.3
TiZr
986.58 (967.45; 1000.34)
863.90 (848.06; 882.43)
12.4
TL
Ti
785.24 (771.82; 786.18)
695.04 (689.27; 705.64)
11.5
TiZr
794.10 (779.74; 795.04)
713.56 (693.69; 726.98)
10.1
1./3.Q, first/third quartile; BL, bone level implants; Ti, titanium alloy; TiZr, titanium zirconium alloy; TL, tissue level implants. Bold values indicate statistical significance
The maximum implant failure strength of regular diameter BL and TL implants ranged from 775.0 to 1029.5 N and from 678.9 to 806.2 N, respectively, while the maximum implant failure strength of narrow diameter implants remained below 650 N (i.e., 441.8 to 644.3 N for narrow diameter BL and 361.2 to 501.2 N for narrow diameter TL implants). BL implants presented a higher range within each group (i.e., 78 to 144 N for the various BL implant groups) compared with TL implants (i.e., 9 to 73 N for the various TL implant groups); however, the range appeared unaffected by IP (Fig. 4). The relative reduction (in %) of the maximum implant failure strength due to IP, based on the median of each group, ranged from 4.2 to 23.0% with the narrow diameter implants, presenting a higher relative reduction in 3 out of 4 comparisons to the regular diameter implants (Table 1).

Impact of IP, implant type/design, diameter, and/or material on implant strength

Multiple linear regression analysis, including all implants, revealed IP, implant type/design, and diameter as statistically significant predictors (p < 0.001; Table 2). Specifically, implants subjected to IP and TL implants presented a statistically significant lower maximum implant failure strength compared with implants without IP and BL implants, respectively, while regular diameter implants presented a statistically significant higher maximum implant failure strength compared with narrow diameter implants. Separate multiple linear regression analyses were also performed for (1) BL and TL implants (Table 3) and (2) narrow and regular diameter implants (Table 4). Both, BL and TL implants, implants subjected to IP and narrow diameter implants presented a statistically significant lower maximum implant failure strength (p < 0.001) compared with implants without IP and regular diameter implants, respectively. Yet, implant material had a statistically significant impact only among TL implants, with TiZr being stronger than Ti (p = 0.002) (Table 3). Regarding narrow and regular diameter implants, for both diameters, implants subjected to IP and TL implants presented a statistically significant lower maximum implant failure strength (p < 0.001) compared with implants without IP and BL implants, respectively. Yet, implant material showed a statistically significant impact only among regular diameter implants, with TiZr being stronger than Ti (p = 0.027) (Table 4).
Table 2
Multiple linear regression analysis with maximum implant failure strength (N) as dependent variable and implantoplasty, implant type/design, diameter, and material as predictors
Parameter
Coefficient
95% Confidence interval
p value
Lower
Upper
Implantoplasty
No
0.0
  
< 0.001
Yes
− 82.90
− 97.40
− 68.40
Implant type/design
Bone level
0.0
  
< 0.001
Tissue level
− 139.96
− 154.46
− 125.46
Implant diameter
Narrow
0.0
  
< 0.001
Regular
347.28
332.74
361.82
Implant material
Ti
0.0
  
0.473
TiZr
5.27
− 9.23
19.77
Ti (titanium) and TiZr (titanium zirconium) alloy. Bold values indicate statistical significance
Table 3
Multiple linear regression analyses separately for BL and TL implants with maximum implant failure strength (N) as dependent variable and implantoplasty, implant diameter, and material as predictors.
Parameter
Coefficient
95% Confidence interval
p value
Lower
Upper
Bone level implants
Implantoplasty
No
0.0
  
< 0.001
Yes
− 82.26
− 105.69
− 58.83
Implant diameter
Narrow
0.0
  
< 0.001
Regular
378.50
355.07
401.93
Implant material
Ti
0.0
  
0.612
TiZr
− 5.96
− 29.39
17.47
Tissue level implants
Implantoplasty
No
0.0
  
< 0.001
Yes
− 81.39
− 90.70
− 72.09
Implant diameter
Narrow
0.0
  
< 0.001
Regular
312.97
303.60
322.34
Implant material
Ti
0.0
  
0.002
TiZr
15.16
5.85
24.46
Ti (titanium) and TiZr (titanium zirconium) alloy. Bold values indicate statistical significance
Table 4
Multiple linear regression analyses separately for narrow and regular diameter implants with maximum implant failure strength (N) as dependent variable and implantoplasty, implant type/design, and material as predictors
Parameter
Coefficient
95% Confidence interval
p value
Lower
Upper
Narrow diameter implants
Implantoplasty
No
0.0
  
< 0.001
Yes
− 67.87
− 89.77
− 45.97
Implant type/design
Bone level
0.0
  
< 0.001
Tissue level
− 102.02
− 123.92
− 80.11
Implant material
Ti
0.0
  
0.298
TiZr
− 11.45
− 33.35
10.45
Regular diameter implants
Implantoplasty
No
0.0
  
< 0.001
Yes
− 92.49
− 107.00
− 77.99
Implant type/design
Bone level
0.0
  
< 0.001
Tissue level
− 170.83
− 185.33
− 156.32
Implant material
Ti
0.0
  
0.027
TiZr
16.42
1.92
30.93
Ti (titanium) and TiZr (titanium zirconium) alloy. Bold values indicate statistical significance

Failure type

Failure type (i.e., implant fracture or bending of the implant and/or prosthetic component > 30°) was recorded for each implant (Figs. 4 and 5). All narrow diameter TL implants and all regular diameter BL implants were fractured before bending > 30° irrespective whether IP was performed or not. All narrow diameter BL implants without IP and all regular diameter TL implants without IP bended > 30° before fracturing, while a few cases from these groups subjected to IP were fractured instead of bending > 30° (i.e., narrow diameter Ti BL implants: 1 case; narrow diameter TiZr BL implants: 2 cases; regular diameter Ti TL implants: 0 cases; regular diameter TiZr TL implants: 2 cases). Interestingly, only 2 regular Ti BL implants without IP were fractured at the neck, while all other fractures occurred at the implant body.

Discussion

Peri-implantitis treatment requires in most cases a surgical approach to get access to the implant surface for decontamination. One approach for implants with a rough surface includes removal of the implant threads and smoothening of the implant surface (i.e., implantoplasty, IP) at the aspects of the implant, where bone healing and/or re-osseointegration is not expected. Since IP unavoidably causes a reduction of the implant mass, it may also weaken the implant and lead to implant fracture. The present laboratory study confirmed that IP causes statistically significant reduction of the maximum implant failure strength, irrespective implant type/design, diameter, and material. Up to now 4 laboratory studies [1416, 18] and one finite element analysis [19] are available on this topic, describing that the impact of IP on implant failure strength appeared to depend on the implant diameter and connection type. Specifically, while wide diameter implants (i.e., 4.7 mm diameter) were not significantly affected by IP [14], contradicting results were reported for regular diameter implants (i.e., 3.75 to 4.3 mm diameter), with 2 studies [15, 18] showing no significant impact of IP on the fracture strength of regular diameter implants, and 2 studies demonstrating statistically significant reduction (up to 40%) in implant failure strength [14, 16]. Further, reduction in fracture strength varied among connection types, with a Morse taper connection being least affected [16]. Herein, IP resulted in significant reduction in implant failure strength in both standard and narrow diameter implants. However, IP seemed to affect more the narrow diameter implants than standard diameter implants, and implant type/design was also shown as a relevant parameter. In contrast to previous data [16], the range of the maximum implant failure strength among the implants within each specific group appeared unaffected by IP; i.e., herein, the range did not increase relevantly in implants subjected to IP. The fact that TL implants are weaker than BL implants is at least partly explained by the fact that TL implants were exposed (i.e., out of the plexiglass holder) at a larger extent compared to BL implants; i.e., 3 mm of the rough surface plus 1.8 mm of the TL neck, thus resulting in a bigger lever. Although previous studies [20, 21] had already indicated that a higher “marginal bone loss” further reduces implant strength, this approach was chosen to simulate a similar amount of horizontal marginal bone loss in both implant types.
In the present study, the impact of IP on narrow diameter implants (i.e., ≤ 3.5 mm) was assessed for the first time. It appears obvious that a smaller diameter implant, which has a thinner metal wall compared to regular/standard diameter implants, would also be more affected from IP. Indeed, fractures during dynamic loading occurred only among narrow diameter TL implants (i.e., 5 out 6 fractures), mainly those subjected to IP. In this context, fracture rate during dynamic loading was clearly lower in narrow TiZr implants compared with narrow Ti implants; i.e., only a single TiZr implant subjected to IP fractured vs. 5 Ti implants. Indeed, the results of the separate multiple linear regression analyses showed that TiZr implants had a statistically significant increased maximum implant failure strength compared with Ti implants, among TL implants and among regular diameter implants. The lack of statistical significance among the narrow diameter implants is most likely due to the high “drop-out rate” among the narrow Ti TL implants subjected to IP. However, the higher fracture rate among narrow Ti TL implants subjected to IP compared with that of narrow TiZr TL implants subjected to IP (i.e., 4 vs. 1 fractures, respectively), in combination with the fact that the highest maximum load value of the narrow Ti TL implants subjected to IP was lower than the lowest maximum load value of the narrow TiZr TL implants subjected to IP, gives a strong indication for an effect of the material also among the narrow implants. Previous laboratory studies have indeed indicated a higher strength of TiZr compared with Ti implants (for overview see: [22]); however, the clinical relevance of these reports is yet unknown. A recent systematic review [23], assessing the clinical performance of narrow diameter Ti and TiZr implants, showed that similar success rates in terms of survival and marginal bone loss, independent of the region in the mouth, are obtained from both types of implants at least on the short-term.
The results herein showed that despite the fact that IP resulted in a statistically significant reduction of the maximum implant failure strength, the forces required to fracture or deformate all regular diameter implants and narrow BL implants remained high (i.e., > 650 and 440 N, respectively). Forces occurring in the natural dentition during regular mastication range between 100 and 300 N [24]. Single implants as well as implant-supported fixed bridges appear to be loaded with similar or slightly lower forces [2527], while loading forces decrease in implant-supported cross-arch restorations, and even more in implant-supported overdentures [2830]. Indeed, no study/case report describing implant fracture after IP was identified in a recent systematic review on mechanical and/or biological complications due to IP [13]. Nevertheless, direct comparison of forces derived from laboratory studies to those from clinical studies should be made with care, due to limitations such as differences in the loading mechanism (i.e., only vertical forces in the laboratory vs. a combination of vertical and horizontal loading forces in the mouth) or in the superstructure geometry (i.e., standardized hemispherical shaped, purpose-made abutments in the laboratory vs. anatomically shaped crowns in the mouth) [31].
The present study shows some important differences/advantages in terms of study design compared with previous laboratory studies on IP. In contrast to previous studies, all implants herein were subjected to dynamic loading prior to loading until failure, to simulate regular mastication and add a certain “aging effect” on the implants [17]. The implants were loaded 2,000,000 cycles, which correspond to the masticatory activity of a couple of years, and the forces applied were within the range of regular chewing forces (i.e., up to 300 N) [24]. Further, IP was performed with a computer-controlled torn, instead of “free hand,” which was used in most of the previous studies [14, 15, 18], to ensure removal of a standardized amount of implant material. Although this approach does not represent the true clinical situation, it ensured that exactly the same amount of metal was removed from every single implant of the various groups. Next, in the present study, a horizontal bone loss of 3 mm was simulated in contrast with the previous laboratory studies simulating 5 to 6 mm bone loss. Thus, the results of the present study may be applicable only in cases of incipient to moderate peri-implantitis (i.e., about 3 mm of bone loss) than to advanced (i.e., ≥ 5 mm of bone loss) peri-implantitis cases. Finally, herein, implant failure was defined as (1) implant fracture or (2) severe deformation of the implant (i.e., bending of the implant and/or prosthetic component > 30°), whichever appeared first. It appeared reasonable that an implant, which is already bended beyond 30°, should be considered failure although fracture may occur only at a later timepoint.
In conclusion, within this laboratory setting, IP significantly reduced maximum implant failure strength, irrespective implant type/design, diameter, or material. However, the maximum implant failure strength of regular diameter and narrow BL implants remained high despite IP (i.e., > 650 and 440 N, respectively), while > 50% of the narrow Ti TL implants subjected to IP were fractured already during dynamic loading, simulating regular mastication. Thus, IP seems to have no clinically relevant impact on the majority of cases, except from those of single narrow Ti TL implants, which may have an increased risk for mechanical complications. The latter should be considered for peri-implantitis treatment planning (e.g., communication of potential complications to the patient), but also in the planning of implant installation (e.g., choosing TiZr instead of Ti for narrow implants).

Acknowledgments

Institut Straumann AG (Basel, CH) donated all implants. Elos Medtech, Gørløse, Denmark donated the prosthetic components and performed the implantoplasty.
The authors wish to thank Camilla Johansson, Department of Dental Material Science and Technology, Faculty of Odontology, University of Malmö, Sweden, for her help with setting up the devices for mechanical testing.

Compliance with ethical standards

Conflict of Interest

Author K. Bertl declares that she has no conflict of interest. Author F. Isidor declares that he has no conflict of interest. Author P. Vult von Steyern declares that he has no conflict of interest, Author A. Stavropoulos declares that he has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.
Not relevant (laboratory study)
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Dent – Das Online-Abo der Zahnmedizin

Online-Abonnement

Mit e.Dent erhalten Sie Zugang zu allen zahnmedizinischen Fortbildungen und unseren zahnmedizinischen und ausgesuchten medizinischen Zeitschriften.

Anhänge

Appendix

Literatur
5.
Zurück zum Zitat Bianchini MA, Galarraga-Vinueza ME, Apaza-Bedoya K, De Souza JM, Magini R, Schwarz F (2019) Two to six-year disease resolution and marginal bone stability rates of a modified resective-implantoplasty therapy in 32 peri-implantitis cases. Clin Implant Dent Relat Res 21:758–765. https://doi.org/10.1111/cid.12773CrossRefPubMed Bianchini MA, Galarraga-Vinueza ME, Apaza-Bedoya K, De Souza JM, Magini R, Schwarz F (2019) Two to six-year disease resolution and marginal bone stability rates of a modified resective-implantoplasty therapy in 32 peri-implantitis cases. Clin Implant Dent Relat Res 21:758–765. https://​doi.​org/​10.​1111/​cid.​12773CrossRefPubMed
7.
Zurück zum Zitat Matarasso S, Iorio Siciliano V, Aglietta M, Andreuccetti G, Salvi GE (2014) Clinical and radiographic outcomes of a combined resective and regenerative approach in the treatment of peri-implantitis: a prospective case series. Clin Oral Implants Res 25:761–767. https://doi.org/10.1111/clr.12183CrossRefPubMed Matarasso S, Iorio Siciliano V, Aglietta M, Andreuccetti G, Salvi GE (2014) Clinical and radiographic outcomes of a combined resective and regenerative approach in the treatment of peri-implantitis: a prospective case series. Clin Oral Implants Res 25:761–767. https://​doi.​org/​10.​1111/​clr.​12183CrossRefPubMed
15.
22.
Zurück zum Zitat Grandin HM, Berner S, Dard M (2012) A review of titanium zirconium (TiZr) alloys for use in endosseous dental implants. Materials 5:1348–1360CrossRef Grandin HM, Berner S, Dard M (2012) A review of titanium zirconium (TiZr) alloys for use in endosseous dental implants. Materials 5:1348–1360CrossRef
23.
Zurück zum Zitat Iegami CM, Uehara PN, Sesma N, Pannuti CM, Tortamano Neto P, Mukai MK (2017) Survival rate of titanium-zirconium narrow diameter dental implants versus commercially pure titanium narrow diameter dental implants: A systematic review. Clin Implant Dent Relat Res 19:1015–1022. https://doi.org/10.1111/cid.12527CrossRefPubMed Iegami CM, Uehara PN, Sesma N, Pannuti CM, Tortamano Neto P, Mukai MK (2017) Survival rate of titanium-zirconium narrow diameter dental implants versus commercially pure titanium narrow diameter dental implants: A systematic review. Clin Implant Dent Relat Res 19:1015–1022. https://​doi.​org/​10.​1111/​cid.​12527CrossRefPubMed
24.
Zurück zum Zitat Vallittu PK, Könönen M (2013) Biomechanical aspects and material properties. A Textbook of Fixed Prosthodontics: The Scandinavian Approach:116–130. Vallittu PK, Könönen M (2013) Biomechanical aspects and material properties. A Textbook of Fixed Prosthodontics: The Scandinavian Approach:116–130.
Metadaten
Titel
Does implantoplasty affect the failure strength of narrow and regular diameter implants? A laboratory study
verfasst von
Kristina Bertl
Flemming Isidor
Per Vult von Steyern
Andreas Stavropoulos
Publikationsdatum
07.09.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 4/2021
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-020-03534-8

Weitere Artikel der Ausgabe 4/2021

Clinical Oral Investigations 4/2021 Zur Ausgabe

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.